Raia Drogasil SA
BOVESPA:RADL3

Watchlist Manager
Raia Drogasil SA Logo
Raia Drogasil SA
BOVESPA:RADL3
Watchlist
Price: 26.02 BRL 2.56% Market Closed
Market Cap: 44.6B BRL
Have any thoughts about
Raia Drogasil SA?
Write Note

Raia Drogasil SA
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Raia Drogasil SA
Other Long-Term Assets Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
Raia Drogasil SA
BOVESPA:RADL3
Other Long-Term Assets
R$451m
CAGR 3-Years
2%
CAGR 5-Years
5%
CAGR 10-Years
42%
Empreendimentos Pague Menos SA
BOVESPA:PGMN3
Other Long-Term Assets
R$609.6m
CAGR 3-Years
38%
CAGR 5-Years
30%
CAGR 10-Years
N/A
Dimed SA Distribuidora de Medicamentos
BOVESPA:PNVL3
Other Long-Term Assets
R$75.8m
CAGR 3-Years
23%
CAGR 5-Years
39%
CAGR 10-Years
18%
d
d1000 Varejo Farma Participacoes SA
BOVESPA:DMVF3
Other Long-Term Assets
R$108.8m
CAGR 3-Years
12%
CAGR 5-Years
25%
CAGR 10-Years
N/A
No Stocks Found

Raia Drogasil SA
Glance View

Market Cap
44.6B BRL
Industry
Retail

Raia Drogasil SA is a leading retail pharmacy chain in Brazil, established through the merger of two prominent companies, Raia and Drogasil, creating a powerhouse in the pharmaceutical and personal care sectors. With a mission to cater to the healthcare and wellness needs of Brazilians, the company operates over 2,300 stores across key urban regions, boasting a comprehensive product range that includes prescription medications, over-the-counter drugs, beauty products, and health-related services. Investors are drawn to Raia Drogasil for its strong market position, supported by a consistent strategy of expansion, innovation, and a commitment to customer service, making it a trusted name in the fast-growing Brazilian pharmaceutical market. In recent years, Raia Drogasil has implemented advanced sales and inventory management systems to enhance operational efficiency and customer satisfaction. The company's focus on growth is further reinforced by a robust online presence, enabling it to capture emerging e-commerce trends among Brazilian consumers. With a resilient business model, anchored by a broad geographic footprint and an increasingly diverse product offering, Raia Drogasil stands poised for long-term success. As Brazil's middle class continues to expand and healthcare spending rises, the company presents a compelling opportunity for investors looking to tap into a thriving market with promising growth potential.

RADL3 Intrinsic Value
20.8 BRL
Overvaluation 20%
Intrinsic Value
Price

See Also

What is Raia Drogasil SA's Other Long-Term Assets?
Other Long-Term Assets
451m BRL

Based on the financial report for Sep 30, 2024, Raia Drogasil SA's Other Long-Term Assets amounts to 451m BRL.

What is Raia Drogasil SA's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 10Y
42%

Over the last year, the Other Long-Term Assets growth was 123%. The average annual Other Long-Term Assets growth rates for Raia Drogasil SA have been 2% over the past three years , 5% over the past five years , and 42% over the past ten years .

Back to Top